Successful drug development for people with cancers of the CNS has been challenging. There are multiple barriers to successful drug development including biological factors, rarity of the disease, and ...

Three different continuous flow strategies for the generation of important 4-aryl-2-butanone derivatives including the anti-inflammatory drug nabumetone [4-(6-methoxy-2-naphthalenyl)-2-butanone] and ...

SK Biopharmaceuticals signed a memorandum of understanding with PhnyX Lab, a U.S.-based AI startup backed by SK Networks, to ...

Both small animal models and microphysiological systems gain in sophistication and value as they expedite in vivo preclinical testing.

Partnership combines AI-powered protein manufacturing with advanced drug delivery technologies to accelerate timelines and improve therapeutic outcomes. MADISON, Wis. and KANSAS CITY, Mo., June 9 ...

IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, announced results of a collaborative research program between IonQ, AstraZeneca, Amazon Web Services (AWS), and NVIDIA ...

A new synthesis of sitagliptin (MK-0431), a DPP-IV inhibitor and potential new treatment for type II diabetes, suitable for the preparation of multi-kilogram quantities is presented. The ...

In the shadow of President Trump's efforts to lower drug prices, the Medicare drug price negotiation process that began in the Biden administration continues. Search Query Show Search.

The FDA has introduced ELSA, a groundbreaking AI tool designed to expedite the review process for drugs and medical devices. In a remarkable pilot, ELSA has proven to significantly reduce the time ...